Concepedia

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber, Henrik Hjorth-Hansen, António Almeida, Jeroen J. W. M. Janssen, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson‐Strömberg, Joaquín Martínez‐López,

The Lancet Oncology · 2018 · 611 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Applied logistic regression

Choice Reviews Online · 1990 · 35.7K citations

, , +15

Bootstrap Methods and Their Application

Thomas M. Loughin, A. C. Davison, D. V. Hinkley · Journal of the American Statistical Association · 1999 · 5.5K citations

, , +11

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text

, , +13

Tutorial in biostatistics: competing risks and multi‐state models

Hein Putter, Marta Fiocco, Ronald B. Geskus · Statistics in Medicine · 2006 · 2.4K citations

, , +9

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

François‐Xavier Mahon, Delphine Réa, Joëlle Guilhot et al. · The Lancet Oncology · 2010 · 1.5K citations

, , +4